MVASI

Google image searchProduct monograph

Active ingredient

bevacizumab, 25 MG/ML

DIN: 02470756

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: 400 MG/16 ML.SINGLE-USE VIAL.

Schedule: Prescription / Schedule D

Company: AMGEN CANADA INC

Date: 01-AUG-2019

ATC:

Reference brand drug: Avastin

Search on Google